XML 30 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Total revenue $ 145,238 $ 109,460 $ 131,836
Operating expenses:      
Cost of goods sold 11,450 4,420 3,818
Research and development 244,990 227,333 201,159
Selling, general and administrative 265,542 197,520 126,284
Restructuring 11,394 0 0
Total operating expenses 533,376 429,273 331,261
Operating loss (388,138) (319,813) (199,425)
Other income (expenses), net:      
Interest income 21,768 6,276 1,993
Interest expense (11,334) (11,014) (19,682)
Other income, net 1,594 974 231
Loss on extinguishment of debt 0 (7,578) 0
Total other income (expense), net 12,028 (11,342) (17,458)
Loss from continuing operations before income tax provision (376,110) (331,155) (216,883)
Income tax provision on continuing operations (223) (313) (409)
Loss from continuing operations, net of tax (376,333) (331,468) (217,292)
Income from discontinued operations, net of tax 264,934 52,986 37,201
Net loss $ (111,399) $ (278,482) $ (180,091)
Basic and diluted:      
Net loss from continuing operations, basic (in dollars per share) $ (5.07) $ (5.20) $ (3.63)
Net loss from continuing operations, diluted (in dollars per share) (5.07) (5.20) (3.63)
Net income from discontinued operations, basic (in dollars per share) 3.57 0.83 0.62
Net income from discontinued operations, diluted (in dollars per share) 3.57 0.83 0.62
Net income (loss) per common share, basic (in dollars per share) (1.50) (4.37) (3.01)
Net income (loss) per common share, diluted (in dollars per share) $ (1.50) $ (4.37) $ (3.01)
Weighted average common shares outstanding, basic (in shares) 74,267,418 63,758,515 59,832,287
Weighted average common shares outstanding, diluted (in shares) 74,267,418 63,758,515 59,832,287
Comprehensive loss:      
Net loss $ (111,399) $ (278,482) $ (180,091)
Unrealized loss on defined benefit pension plan (374) (368) 0
Foreign currency translation (loss) gain (1,871) 507 1,515
Unrealized gain (loss) on marketable debt securities 3,696 (2,484) (1,175)
Comprehensive loss (109,948) (280,827) (179,751)
Net product sales      
Total revenue 127,537 97,970 115,122
Operating expenses:      
Cost of goods sold 8,406 4,420 3,818
License and collaboration revenue      
Total revenue 17,701 11,490 16,714
Operating expenses:      
Cost of goods sold $ 3,044 $ 0 $ 0